COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #153
Source   PDF   Share   Tweet
See all 181 studies
10/23
Positive
Late treatment study
Coll et al., American Journal of Transplantation, doi:10.1111/ajt.16369 (Peer Reviewed)
Covid‐19 in transplant recipients: the spanish experience
Retrospective 652 transplant recipient patients in Spain showing 46% lower mortality for patients treated with HC Q, unadjusted relative risk RR 0.54, p<0.0001.
death, ↓45.6%, p<0.0001
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.
Submit